EF1A2_XENLA
ID EF1A2_XENLA Reviewed; 461 AA.
AC P17507; Q68FJ2;
DT 01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT 01-AUG-1990, sequence version 1.
DT 03-AUG-2022, entry version 125.
DE RecName: Full=Elongation factor 1-alpha, oocyte form;
DE Short=EF-1-alpha-O;
DE Short=EF-1AO;
DE AltName: Full=42S p48;
GN Name=eef1ao;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Oocyte;
RX PubMed=2362804; DOI=10.1093/nar/18.12.3489;
RA Dje M.K., Mazabraud A., Viel A., le Maire M., Denis H., Crawford E.T.,
RA Brown D.D.;
RT "Three genes under different developmental control encode elongation factor
RT 1-alpha in Xenopus laevis.";
RL Nucleic Acids Res. 18:3489-3493(1990).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC TISSUE=Oocyte;
RX PubMed=1765266; DOI=10.1016/0378-1119(91)90608-e;
RA Frydenberg J., Poulsen K., Petersen A.K.B., Lund A., Olesen O.F.;
RT "Isolation and characterization of the gene encoding EF-1 alpha O, an
RT elongation factor 1-alpha expressed during early development of Xenopus
RT laevis.";
RL Gene 109:185-192(1991).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Kidney;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN [4]
RP NUCLEOTIDE SEQUENCE [MRNA] OF 139-461.
RX PubMed=1988459; DOI=10.1083/jcb.112.2.237;
RA Coppard N.J., Poulsen K., Madsen H.O., Frydenberg J., Clark B.F.C.;
RT "42Sp48 in previtellogenic Xenopus oocytes is structurally homologous to
RT EF-1 alpha and may be a stage-specific elongation factor.";
RL J. Cell Biol. 112:237-243(1991).
RN [5]
RP PARTIAL PROTEIN SEQUENCE.
RX PubMed=1894690; DOI=10.1083/jcb.114.6.1109;
RA Deschamps S., Morales J., Mazabraud A., le Maire M., Denis H., Brown D.D.;
RT "Two forms of elongation factor 1 alpha (EF-1 alpha O and 42Sp50), present
RT in oocytes, but absent in somatic cells of Xenopus laevis.";
RL J. Cell Biol. 114:1109-1111(1991).
CC -!- FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-
CC tRNA to the A-site of ribosomes during protein biosynthesis.
CC -!- SUBCELLULAR LOCATION: Cytoplasm.
CC -!- TISSUE SPECIFICITY: Oocyte.
CC -!- DEVELOPMENTAL STAGE: 3 EF-1-alpha are expressed under different
CC developmental control in Xenopus laevis.
CC -!- SIMILARITY: Belongs to the TRAFAC class translation factor GTPase
CC superfamily. Classic translation factor GTPase family. EF-Tu/EF-1A
CC subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X52976; CAA37168.1; -; mRNA.
DR EMBL; M67485; AAA49702.1; -; Genomic_DNA.
DR EMBL; M67481; AAA49702.1; JOINED; Genomic_DNA.
DR EMBL; M67483; AAA49702.1; JOINED; Genomic_DNA.
DR EMBL; M67484; AAA49702.1; JOINED; Genomic_DNA.
DR EMBL; M75873; AAA49701.1; -; Genomic_DNA.
DR EMBL; BC079786; AAH79786.1; -; mRNA.
DR EMBL; X56698; CAA40028.1; -; mRNA.
DR PIR; JH0530; JH0530.
DR RefSeq; NP_001081521.1; NM_001088052.1.
DR AlphaFoldDB; P17507; -.
DR SMR; P17507; -.
DR BioGRID; 99228; 3.
DR IntAct; P17507; 2.
DR DNASU; 397890; -.
DR GeneID; 397890; -.
DR KEGG; xla:397890; -.
DR CTD; 397890; -.
DR Xenbase; XB-GENE-1218993; eef1a1o.L.
DR OMA; DPPMQAG; -.
DR OrthoDB; 1150082at2759; -.
DR Proteomes; UP000186698; Chromosome 2L.
DR Bgee; 397890; Expressed in ovary and 16 other tissues.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR Gene3D; 3.40.50.300; -; 1.
DR HAMAP; MF_00118_A; EF_Tu_A; 1.
DR InterPro; IPR004161; EFTu-like_2.
DR InterPro; IPR031157; G_TR_CS.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR000795; T_Tr_GTP-bd_dom.
DR InterPro; IPR009000; Transl_B-barrel_sf.
DR InterPro; IPR009001; Transl_elong_EF1A/Init_IF2_C.
DR InterPro; IPR004539; Transl_elong_EF1A_euk/arc.
DR InterPro; IPR004160; Transl_elong_EFTu/EF1A_C.
DR Pfam; PF00009; GTP_EFTU; 1.
DR Pfam; PF03144; GTP_EFTU_D2; 1.
DR Pfam; PF03143; GTP_EFTU_D3; 1.
DR PRINTS; PR00315; ELONGATNFCT.
DR SUPFAM; SSF50447; SSF50447; 1.
DR SUPFAM; SSF50465; SSF50465; 1.
DR SUPFAM; SSF52540; SSF52540; 1.
DR TIGRFAMs; TIGR00483; EF-1_alpha; 1.
DR PROSITE; PS00301; G_TR_1; 1.
DR PROSITE; PS51722; G_TR_2; 1.
PE 1: Evidence at protein level;
KW Cytoplasm; Direct protein sequencing; Elongation factor; GTP-binding;
KW Methylation; Nucleotide-binding; Phosphoprotein; Protein biosynthesis;
KW Reference proteome.
FT INIT_MET 1
FT /note="Removed"
FT /evidence="ECO:0000250|UniProtKB:P68104"
FT CHAIN 2..461
FT /note="Elongation factor 1-alpha, oocyte form"
FT /id="PRO_0000090900"
FT DOMAIN 5..242
FT /note="tr-type G"
FT REGION 14..21
FT /note="G1"
FT /evidence="ECO:0000250"
FT REGION 70..74
FT /note="G2"
FT /evidence="ECO:0000250"
FT REGION 91..94
FT /note="G3"
FT /evidence="ECO:0000250"
FT REGION 153..156
FT /note="G4"
FT /evidence="ECO:0000250"
FT REGION 194..196
FT /note="G5"
FT /evidence="ECO:0000250"
FT BINDING 14..21
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 91..95
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 153..156
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT MOD_RES 2
FT /note="N,N,N-trimethylglycine"
FT /evidence="ECO:0000250|UniProtKB:P68104"
FT MOD_RES 301
FT /note="5-glutamyl glycerylphosphorylethanolamine"
FT /evidence="ECO:0000250"
FT MOD_RES 374
FT /note="5-glutamyl glycerylphosphorylethanolamine"
FT /evidence="ECO:0000250"
SQ SEQUENCE 461 AA; 50123 MW; 2CCDC71C6EA245A2 CRC64;
MGKEKIHINI VVIGHVDSGK STTTGHLIYK CGGIDKRTIE KFEKEAAEMG KGSFKYAWVL
DKLKAERERG ITIDISLWKF ETGKFYITII DAPGHRDFIK NMITGTSQAD CAVLIVAGGV
GEFEAGISKN GQTREHALLA FTLGVKQLII GVNKMDSTEP PFSQKRFEEI TKEVSAYIKK
IGYNPATVPF VPISGWHGDN MLEASTNMPW FKGWKIERKE GNASGVTLLE ALDCIIPPQR
PTAKPLRLPL QDVYKIGGIG TVPVGRVETG VLKPGMIVTF APSNVTTEVK SVEMHHEALQ
EALPGDNVGF NVKNISVKDI RRGNVAGDSK NDPPMQAGSF TAQVIILNHP GQISAGYAPV
LDCHTAHIAC KFAELKQKID RRSGKKLEDD PKFLKSGDAA IVEMIPGKPM CVESFSDYPP
LGRFAVRDMR QTVAVGVIKG VDKKAASSGK VTKSAVKAGK K